Sarepta Therapeutics SRPT
NASDAQ SRPT
$17.50 -0.07 (-0.40%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sarepta Therapeutics (SRPT) Selling, General & Administrative (2010 - 2026)

Updated

Sarepta Therapeutics' Selling, General & Administrative came in at $107.6 million for Q2 2026, down 22.0% from $137.9 million a year earlier and down 1.2% from the prior quarter.

Analysis

Sarepta Therapeutics (SRPT) Selling, General & Administrative (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Sarepta Therapeutics reported Selling, General & Administrative of $436.74 million, down 22.5% year-over-year; for FY2025, it was $491.72 million, down 11.9% from FY2024.

  • Selling, General & Administrative carries a five-year compound annual growth rate of 9.1% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $557.87 million in FY2024 (+15.8%), $481.87 million in FY2023 (+6.7%), $451.42 million in FY2022 (+59.7%) and $282.66 million in FY2021 (-11.1%).
  • The five-year range for quarterly Selling, General & Administrative is $61.13 million (Q3 2021) to $163.87 million (Q4 2024).
  • Year-over-year, Selling, General & Administrative has declined for five consecutive quarters, with an average decline of 6.9% over the last eight quarters.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q2 2022 (growth of 113.3%), and the weakest in Q3 2025 (a decline of 28.3%).
  • Business Quant data shows SRPT's Selling, General & Administrative at $108.95 million (Q1 2026), $128.3 million (Q4 2025) and $91.89 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Sarepta Therapeutics 1.86 Bn -1.38 Bn 251.87 Mn 107.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 107.60 Mn
Mar 31, 2026 108.95 Mn
Dec 31, 2025 128.30 Mn
Sep 30, 2025 91.89 Mn
Jun 30, 2025 137.90 Mn
Mar 31, 2025 133.63 Mn
Dec 31, 2024 163.87 Mn
Sep 30, 2024 128.20 Mn
Jun 30, 2024 138.80 Mn
Mar 31, 2024 127.00 Mn
Dec 31, 2023 131.70 Mn
Sep 30, 2023 120.89 Mn
Jun 30, 2023 118.56 Mn
Mar 31, 2023 110.71 Mn
Dec 31, 2022 120.48 Mn
Sep 30, 2022 104.79 Mn
Jun 30, 2022 154.32 Mn
Mar 31, 2022 71.84 Mn
Dec 31, 2021 78.06 Mn
Sep 30, 2021 61.13 Mn
API Access

Sarepta Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=SRPT&period=max&api_key=YOUR_API_KEY